Description
GLP-3-R is a novel triple-action receptor agonist that targets GLP-1, GIP, and glucagon receptors simultaneously. Clinical research has demonstrated significant results in metabolic function and body composition studies.
Desired Effects
- Fat Loss
- Appetite Control
- Blood Sugar Support
- Metabolic Function
- GLP-1 / GIP / GCGR Agonist
- Energy Expenditure
Purity: 99.5% | Janoshik Tested | USA Based
For research use only. Not for human consumption.





Reviews
There are no reviews yet.